Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: ADTX

Aditxt, Inc.

Healthcare | Biotechnology
$0.00 -0.00 (-9.38%)
Volume6.35M

Aditxt, Inc. (NASDAQ: ADTX) is a biotechnology company trading at $0.00 (−9.4% today). Figures from SEC EDGAR and market feeds; updated 2026-10-11 00:45 UTC.

What Aditxt, Inc. does

The company was incorporated in Delaware and is headquartered in Mountain View, California, with a mission to transform how health innovations are discovered, developed, and deployed by engaging broad groups of stakeholders. The company's main focus is through its subsidiary Adimune, Inc., which develops immune modulation therapies based on Apoptotic DNA Immunotherapy (ADI), a technology licensed from Loma Linda University.

Summarized from Aditxt, Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Quote
Price$0.00
Change (1D)-0.00 (-9.38%)
Volume6.35M shares
Valuation
Return on equity-768.34%
Debt/equity0.33

Revenue, margins & earnings

FY2021: net loss $46M on revenue $105,034$105,034FY2021FY2022: net loss $28M on revenue $933,715$933,715FY2022FY2023: net loss $33M on revenue $645,176$645,176FY2023FY2024: net loss $40M on revenue $133,985$133,985FY2024FY2025: net loss $43M on revenue $3,195$3,195FY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
  • Net loss year
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity
Source: SEC EDGAR · Filed 2026-06-25
Most recent filed transactions — June 2026:
  • 2026-06-2510% OwnerSale-3,420,439$68.4K
  • 2026-06-2410% OwnerSale-5,120,480$92.2K
  • 2026-06-2410% OwnerPurchase7,340,178$95.4K
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →
No qualifying company news in the archive. Full tape in the platform →

Questions this page answers

What does Aditxt, Inc. do?

The company was incorporated in Delaware and is headquartered in Mountain View, California, with a mission to transform how health innovations are discovered, developed, and deployed by engaging broad groups of stakeholders.

What is ADTX's valuation?

ADTX trades at $0.00, as of 2026-10-11.

When did ADTX last file with the SEC?

Aditxt, Inc.'s most recent SEC filing on record is a 8-K filed 2026-09-23. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings and public market data feeds, fetched 2026-10-11 00:45 UTC. This page is also available as JSON at /api/data?ticker=ADTX and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for ADTX and 5,000+ tickers.

Create a free account — keep ADTX
For your agent
GET /api/data?ticker=ADTX

This page as JSON via rel="alternate" · REST API docs · MCP server (62 tools) · llms.txt